The use of cytokines and chemokines as genetic adjuvants for plasmid DNA vaccines
Authors:
- Michael A EganMEMichael A Egan
- Zimra R IsraelZIZimra R Israel
- 1 July 2002
- journal article
- Published by Elsevier in Clinical and Applied Immunology Reviews
- Vol. 2 (4-5) , 255-287
Abstract
No abstract availableThis publication has 183 references indexed in Scilit:
- Immunization of animals: from DNA to the dinner plateVeterinary Immunology and Immunopathology, 1999
- Immunological memory after somatic transgene immunization is positively affected by priming with GM-CSF and does not require bone marrow- derived dendritic cellsEuropean Journal of Immunology, 1998
- IL-12 as an adjuvant for cell-mediated immunitySeminars in Immunology, 1997
- HIV suppression by interleukin-16Nature, 1995
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- The immunobiology of muscleImmunology Today, 1994
- DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibodyHuman Molecular Genetics, 1993
- Non-inflammatory peptide fragments of IL1 as safe new-generation adjuvantsResearch in Immunology, 1992
- Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.Journal of Experimental Medicine, 1992
- Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.Journal of Experimental Medicine, 1987